CliffBio
small molecule

GLYCOPYRRONIUM TOSYLATE

GLYCOPYRRONIUM TOSYLATE

Loss of exclusivity—loss of exclusivity
CompanyPADAGIS US LLC

Drug detail

Brand nameGLYCOPYRRONIUM TOSYLATE
Active ingredientGLYCOPYRRONIUM TOSYLATE
StrengthEQ 2.4% BASE
Dosage formCLOTH
RouteTOPICAL
ModalitySmall molecule
FDA approvalApril 2026
Marketing statusDISCN

More from PADAGIS US LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

GLYCOPYRRONIUM TOSYLATE patent cliff — loss of exclusivity — | CliffBio